Christopher Lieu

23PUBLICATIONS
148CO-AUTHORS
Applied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Cancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsMedical genetics (excl. cancer genetics)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (23)

|May 01, 2026
Immunotherapy in Localized Colorectal Cancer: Current Practice and Future Directions.

|Jan 13, 2026
Ensuring the Future of Cooperative Group Cancer Clinical Trials: A Call for Comprehensive Support and Prioritization.

Christopher H Lieu, Hanna K Sanoff

|Jan 07, 2026
NCI9673 (Part B): ETCTN Randomized Phase II Study of Nivolumab With or Without Ipilimumab in Refractory, Metastatic Squamous Cell Carcinoma of the Anal Canal.

Van K Morris, Kristen K Ciombor, Lianchun Xiao

|Oct 31, 2025
Phase II Clinical Trial and Preclinical Evaluation of a Novel CD47 Blockade Combination in Refractory Microsatellite-Stable Metastatic Colorectal Cancer.

Robert W Lentz, Julie Lang, Todd M Pitts

|Sep 24, 2025
Benchmarking the Current Landscape: Insights From an Association of American Cancer Institutes Survey on Academic Cancer Service Lines.

Paula M Fracasso, Nicole L Simone, Stephanie J Si Lim

|Sep 18, 2025
A First-In-Human Dose-Escalation Phase I Study of Basroparib, a Tankyrase Inhibitor, in Patients with Advanced-Stage Solid Tumors.

Christopher H Lieu, Heinz-Josef Lenz, Al B Benson

Pageof 4

Frequent Collaborators

4 joint publications

Sunnie S Kim

4 joint publications

Robert W Lentz

4 joint publications

Wells A Messersmith

3 joint publications

Alexis D Leal